1 | ONCOANCF ;Hines OIFO/GWB - ACOS Reporting Paramenters ;06/14/00
|
---|
2 | ;;2.11;ONCOLOGY;**1,15,25,26**;Mar 07, 1995
|
---|
3 | DATA ;
|
---|
4 | ;;RECORD TYPE^1^1
|
---|
5 | ;;Patient ID number^2^9
|
---|
6 | ;;Registry type^10^10
|
---|
7 | ;;Registry ID^11^18
|
---|
8 | ;;Address at diagnosis-city^19^38
|
---|
9 | ;;Address at diagnosis-state^39^40
|
---|
10 | ;;County of residence at diagnosis^41^43
|
---|
11 | ;;Address at diagnosis-ZIP^44^52
|
---|
12 | ;;Blank^53^59
|
---|
13 | ;;Marital status^60^60
|
---|
14 | ;;Race^61^62^1
|
---|
15 | ;;Race coding system - Current^63^63
|
---|
16 | ;;Race coding system - Original^64^64
|
---|
17 | ;;Spanish Surname/Origin (Ethnicity)^65^65^1
|
---|
18 | ;;Sex^66^66^1
|
---|
19 | ;;Age at diagnosis^67^69
|
---|
20 | ;;Date of birth^70^77^1
|
---|
21 | ;;Place of birth^78^80
|
---|
22 | ;;Religon^81^82
|
---|
23 | ;;Blank^83^106
|
---|
24 | ;;Tumor record number^107^108
|
---|
25 | ;;Sequence number^109^110^1
|
---|
26 | ;;Date of initial diagnosis^111^118^1
|
---|
27 | ;;Primary site^119^122^1
|
---|
28 | ;;Laterality^123^123^1
|
---|
29 | ;;Histology^124^128^1
|
---|
30 | ;;Grade or differentiation^129^129^1
|
---|
31 | ;;Site coding system - Current^130^130
|
---|
32 | ;;Site coding system - Original^131^131
|
---|
33 | ;;Morphology coding system - Current^132^132
|
---|
34 | ;;Blank^133^133
|
---|
35 | ;;Diagnostic confirmation^134^134^1
|
---|
36 | ;;Type of reporting source^135^135
|
---|
37 | ;;Accession year^136^137^1
|
---|
38 | ;;Blank^138^141
|
---|
39 | ;;Reporting (diagnosis) hospital^142^149
|
---|
40 | ;;Accession number (hospital)^150^155^1
|
---|
41 | ;;Blank^156^158
|
---|
42 | ;;Date of admission^159^166
|
---|
43 | ;;Date of discharge^167^174
|
---|
44 | ;;Class of case^175^175^1
|
---|
45 | ;;RX hospital-surgery type^176^177
|
---|
46 | ;;RX hospital-radiation^178^178
|
---|
47 | ;;RX hospital-chemotherapy^179^179
|
---|
48 | ;;RX hospital-hormone/steroid^180^180
|
---|
49 | ;;RX hospital-biological response modifier^181^181
|
---|
50 | ;;RX hospital-other cancer-directed therapy^182^182
|
---|
51 | ;;General Summary Stage^183^183^1
|
---|
52 | ;;Local/Regional/Distant stage^184^184
|
---|
53 | ;;EOD-Tumor size^185^187^1
|
---|
54 | ;;EOD-Extension^188^189
|
---|
55 | ;;EOD-Lymph nodes^190^190
|
---|
56 | ;;Regional nodes positive^191^192^1
|
---|
57 | ;;Regional nodes examined^193^194^1
|
---|
58 | ;;Blank^195^213
|
---|
59 | ;;T code of TNM (pathologic)^214^215^2:221,222
|
---|
60 | ;;N code of TNM (pathologic)^216^217^2:223,224
|
---|
61 | ;;M code of TNM (pathologic)^218^218^2:225,225
|
---|
62 | ;;AJCC Stage Group (Path)^219^220^2:226,227
|
---|
63 | ;;T code (Clinical)^221^222^2:214,215
|
---|
64 | ;;N code (Clinical)^223^224^2:216,217
|
---|
65 | ;;M code (Clinical)^225^225^2:218,218
|
---|
66 | ;;AJCC Stage Group (Clinical)^226^227^2:219,220
|
---|
67 | ;;TNM Edition Number^228^228
|
---|
68 | ;;Distant Metastasis^229^231^1
|
---|
69 | ;;Surgical Margins^232^232
|
---|
70 | ;;Blank^233^236
|
---|
71 | ;;Tumor Marker 1^237^237
|
---|
72 | ;;Tumor Marker 2^238^238
|
---|
73 | ;;Blank^239^250
|
---|
74 | ;;Treatment coding system^251^251
|
---|
75 | ;;RX date-surgery^252^259
|
---|
76 | ;;RX date-radiation^260^267
|
---|
77 | ;;RX date-chemotherapy^268^275
|
---|
78 | ;;RX date-hormone/steroid therapy^276^283
|
---|
79 | ;;RX date-biological response modifier^284^291
|
---|
80 | ;;RX date-other cancer-directed therapy^292^299
|
---|
81 | ;;RX date-started^300^307^1
|
---|
82 | ;;RX summary-surgery type^308^309^1
|
---|
83 | ;;Reason for no cancer-directed surgery^310^310
|
---|
84 | ;;RX summary-radiation^311^311^1
|
---|
85 | ;;Radiation to brain and central nervous system^312^312
|
---|
86 | ;;RX summary-Radiation therapy sequence with surgery^313^313
|
---|
87 | ;;RX summary-chemotherapy^314^314^1
|
---|
88 | ;;RX summary-hormone/steroid (endocrine) therapy^315^315
|
---|
89 | ;;RX summary-biological response modifier^316^316^1
|
---|
90 | ;;RX summary-other cancer-directed therapy^317^317^1
|
---|
91 | ;;Blank^318^337
|
---|
92 | ;;#1 Subsequent RX-date (started)^338^345^
|
---|
93 | ;;#1 Surgery^346^347^
|
---|
94 | ;;#1 Radiation^348^348
|
---|
95 | ;;#1 Chemotherapy^349^349
|
---|
96 | ;;#1 Hormone/steroid therapy^350^350
|
---|
97 | ;;#1 Biological response modifier^351^351
|
---|
98 | ;;#1 Other cancer-directed therapy^352^352
|
---|
99 | ;;#2 Subsequent RX-date (started)^353^360
|
---|
100 | ;;#2 Surgery^361^362
|
---|
101 | ;;#2 Radiation^363^363
|
---|
102 | ;;#2 Chemotherapy^364^364
|
---|
103 | ;;#2 Hormone/steroid therapy^365^365
|
---|
104 | ;;#2 Biological response modifier^366^366
|
---|
105 | ;;#2 Other cancer-directed therapy^367^367
|
---|
106 | ;;#3 Subsequent RX-date (started)^368^375
|
---|
107 | ;;#3 Surgery^376^377
|
---|
108 | ;;#3 Radiation^378^378
|
---|
109 | ;;#3 Chemotherapy^379^379
|
---|
110 | ;;#3 Hormone/steroid therapy^380^380
|
---|
111 | ;;#3 Biological response modifier^381^381
|
---|
112 | ;;#3 Other cancer-directed therapy^382^382
|
---|
113 | ;;#4 Subsequent RX-date (started)^383^390
|
---|
114 | ;;#4 Surgery^391^392
|
---|
115 | ;;#4 Radiation^393^393
|
---|
116 | ;;#4 Chemotherapy^394^394
|
---|
117 | ;;#4 Hormone/steroid therapy^395^395
|
---|
118 | ;;#4 Biological response modifier^396^396
|
---|
119 | ;;#4 Other cancer-directed therapy^397^397
|
---|
120 | ;;Blank^398^417
|
---|
121 | ;;Date of last contact^418^425^1
|
---|
122 | ;;Vital status^426^426^1
|
---|
123 | ;;Cancer status^427^427^1
|
---|
124 | ;;Quality of survival^428^428
|
---|
125 | ;;Blank^429^460
|
---|
126 | ;;First recurrence-date^461^468^
|
---|
127 | ;;First recurrence-type^469^469^
|
---|
128 | ;;First recurrence-distant site(s)^470^472^
|
---|
129 | ;;Cause of death^473^476
|
---|
130 | ;;ICD revision number^477^477
|
---|
131 | ;;Blank^478^481
|
---|
132 | ;;Blank^482^502
|
---|
133 | ;;Blank^503^522
|
---|
134 | ;;ACOS coding system - Current^523^523
|
---|
135 | ;;Blank^524^525
|
---|
136 | ;;Vendor Name^526^535
|
---|
137 | ;;AACCR Record Version^536^536
|
---|
138 | ;;Blank^537^550
|
---|
139 | ;;
|
---|
140 | ;;
|
---|